Mr Mrs Miss Ms Dr Other

Dr
Yulia
Ryabenkova

Patent Attorney

Sheffield Office

Engineering

Telephone. +44(0) 114 274 3700
Email. [email protected]

Experience

Yulia’s expertise lies in the area of materials science and engineering. She specialises in various aspects of materials manufacturing and technology with a particular emphasis on medical devices. Her main areas of interest lie in the prosecution, searching and competitor monitoring, as well as IP audits.

Yulia obtained her Masters (Hons) Degree in Chemistry from Tula State University, Russia in 2005.

She then worked for the Russian Police Force as a forensic expert/crime scene investigator, specialising in forensic analytical chemistry. In 2009 she moved to the UK to undertake her PhD in the chemistry of materials for the manufacturing of fine chemicals and commodities, which she completed in 2012.

In 2013-17 she worked as a Postdoctoral Researcher at the Universities of Sheffield and Bradford where she focused on managing a number of projects in the areas of biomedical and pharmaceutical engineering.

Having worked in collaboration with several SMEs from both the UK and EU as part of her research activities, she used her experience and knowledge in the area of materials engineering and technology for orthopaedics and drug delivery systems to bridge the gap between industries and academia.

She is an Associate Fellow of the Higher Education Academy since July 2016.

Qualifications

Patent Attorney

Europe


MCHEM

Chemistry

PHD

Chemistry

Publications

Exam Success!

View publication online

Related News

EPO Annual Fee Increases

The European Patent Office (EPO) has announced that revised Official Fees will apply to payments made on or after Monday 1st April 2024. The majority of fees will increase by …

Read article
Event - 30th January 2024

CAR-TCR Summit, Europe 2024

HGF are proud Event Partners of CAR-TCR Europe, which is due to go ahead from 27th – 29th February at ExCeL, Royal Victoria Dock in London. This is the European hub …

Event details

First CRISPR therapy approved for use in the UK

In an unprecedented move, the MHRA has approved a CRISPR gene editing therapy ‘Casgevy’  for the treatment of sickle cell disease and beta-thalassaemia in patients with recurrent vaso-occlusive crises. The Casgevy …

Read article
Event - 8th, 22nd February 2024

Dresden & Salzburg Seminar: Invention and patent searches in public databases

HGF is pleased to invite you to our upcoming German-language seminar on “Invention and patent searches in public databases” in Salzburg and Dresden. The seminar will showcase how public databases …

Event details
Event - 29th November 2023

HGF & Shiga Webinar Recording: Medical devices and bioinformatics / AI diagnostic feedback - law and practice in Europe and Japan

“Medical devices and bioinformatics / AI diagnostic feedback – law and practice in Europe and Japan” The EPC does not allow ‘medical use’ claims for medial devices. So how do …

Event details

Blog Series: IP Ingredients, Part 1: Can you patent a recipe?

A patent is a legal right that enables the patent holder to prevent others from making and using their invention in the country where the patent is granted.  To many …

Read article

UPC and Forum Shopping – Rule 17.3

Order of the classifications listed on the front of a patent and why it matters? On 1 June 2023, ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE lodged a statement of revocation of …

Read article
Event - 16th November 2023

Webinar in cooperation with the BVIZ: Licensing and Technology Transfer

HGF is pleased to invite you to our upcoming German-language webinar in cooperation with the BVIZ on “In- and Out-licensing of Technologies” on 16th of November 2023. The webinar will …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.